Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2019 16:31 ET | Source: MannKind

MannKind Corporation to Hold 2018 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2019

WESTLAKE VILLAGE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2018 fourth quarter and full year financial results on Tuesday, February 26, 2019 and...
January 16, 2019 16:30 ET | Source: MannKind

MannKind Announces Direct Purchase Insulin Program Providing Afrezza® for as low as $4 a Day

WESTLAKE VILLAGE, Calif., Jan. 16, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
December 27, 2018 08:00 ET | Source: MannKind

MannKind Corporation to Hold Investor Conference Call

WESTLAKE VILLAGE, Calif., Dec. 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) will host a conference call on Friday, January 4, 2019 to discuss Company developments at 9:00 AM...
December 19, 2018 23:57 ET | Source: MannKind

MannKind Announces Pricing of $40 Million Public Offering

WESTLAKE VILLAGE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) (MannKind) today announced the pricing of an underwritten public offering of 26,666,667 shares of its...
December 19, 2018 16:01 ET | Source: MannKind

MannKind Announces Commencement of Public Offering

WESTLAKE VILLAGE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) (MannKind) today announced that it has commenced an underwritten public offering to issue and sell...
November 27, 2018 09:00 ET | Source: MannKind

MannKind Appoints Christine Mundkur to its Board of Directors

WESTLAKE VILLAGE, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that Christine Mundkur has joined its Board of Directors, effective November 27, 2018....
November 01, 2018 08:00 ET | Source: MannKind

MannKind Corporation Reports 2018 Third Quarter Financial Results

Conference Call to Begin Today at 9:00 AM ET Executed license and collaboration agreement with United Therapeutics for up to $95 million in upfront and milestone payments plus royaltiesExecuted...
October 25, 2018 17:00 ET | Source: MannKind

MannKind Corporation to Hold 2018 Third Quarter Financial Results Conference Call on November 1, 2018

WESTLAKE VILLAGE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will host a conference call to discuss the 2018 third quarter and year-to-date financial results and...
October 16, 2018 06:00 ET | Source: MannKind

United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement

RESEARCH TRIANGLE PARK, N.C. and WESTLAKE VILLAGE, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- United Therapeutics Corporation (Nasdaq: UTHR) and MannKind Corporation (Nasdaq: MNKD) today announced...
October 15, 2018 09:00 ET | Source: MannKind

Afrezza® Inhaled Insulin Television Advertising Campaign Wins Gold Award for Creativity

Broadcast spot recognized at 2018 Medical Marketing & Media (MM&M) Awards WESTLAKE VILLAGE, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a company focused...